# MLN3126 Single Rising Dose Study

> **NCT02447458** · PHASE1 · TERMINATED · sponsor: **Takeda** · enrollment: 39 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MLN3126
- **DRUG:** MLN3126 Placebo

## Key facts

- **NCT ID:** NCT02447458
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Site non-compliance to GCP (No safety concerns. See detailed description)
- **Last updated:** 2015-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447458, "MLN3126 Single Rising Dose Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02447458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*